CClinicalTrials.gg
Status unknownNCT02208414Updated Aug 5, 2014

Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques

An interventional study of NAET and NAET in Food Allergies, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2014-08-05.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2014), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

Purpose of this study is to determine whether NAET procedures are effective in the treatment of crab or shrimp allergy.

Hypothesis: experimental group will show a significant improvement over the control group in allergic symptom, serum crab- or shrimp-specific IgE and skin test for crab or shrimp extract.

Read the detailed description

Nambudripad allergy elimination techniques (NAET) were developed by Dr. Devi Nambudripad in 1983. Many patients have been relieved of allergy and allergy-related disease by this treatment.

Lack of well-controlled clinical study prevents NAET from being accepted as a treatment option in current medical system.

The aim of this project is to conduct a double blind-placebo controlled study of applying NAET to treat crab or shrimp allergy.

The parameters to be measured are allergic symptom, crab- or shrimp-specific IgE and skin test before and after NAET treatment

02

Conditions studied

  • Food Allergies

Keywords

  • Food Allergies
03

In context

Hypersensitivity

1,916 studies on the registry are indexed under Hypersensitivity; 265 are open to participants now.

This study's enrollment of 80 is above the median of 57 across 1,384 interventional studies indexed under Hypersensitivity.

Browse Hypersensitivity studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Older or equal to 20 years old
  • History of allergic to crab or shrimp
  • Positive serum crab- or shrimp-specific IgE

Exclusion criteria

Exclusion Criteria:

  • History of anaphylactic shock
  • On medication of anti-histamine or steroid
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Crab or shrimp

    Intervention: treated with crab and shrimp energy signature vial using NAET

    Procedure: NAET

  • Placebo comparator
    Placebo

    Treated with water vial

    Procedure: NAET

Interventions

  • ProcedureNAET

    NAET with acupressure and/or chiropractic procedures with the participant holding crab and shrimp energy signature vial

  • ProcedureNAET

    NAET with acupressure and/or chiropractic procedures with the participant holding water vial

06

What researchers measure

Primary outcomes

  1. Change from Baseline in allergic symptoms at 6 months

    Symptoms when exposed to crab or shrimp which include symptoms of skin, eye, respiratory tract, gastrointestinal tract, cardiovascular system and others. The participants give score subjectively from 0 to 10 according to the severity of the symptoms.

    Time frame: before NAET and 6 months after NAET

Secondary outcomes

  1. Serum crab- or shrimp-specific IgE

    Time frame: before NAET, 1 month, 3 months and 6 months after NAET

  2. Skin test

    Skin test for crab or shrimp extract

    Time frame: before NAET, 1 month and 6 months after NAET

07

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02208414
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Aug 5, 2014
Start date
Jun 2012
Primary completion
Jul 2014
Completion
Dec 2014 (estimated)
Last update
Aug 5, 2014

Study contacts

Cha Ze Lee, MD, PhD
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion